Insider Transactions in Q2 2021 at Coherus Bio Sciences, Inc. (CHRS)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 09
2021
|
Mc David Stilwell Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
3,700
+9.53%
|
$48,100
$13.42 P/Share
|
|
Jun 08
2021
|
Dennis M Lanfear President & CEO |
SELL
Open market or private sale
|
Direct |
31,054
-5.92%
|
$403,702
$13.56 P/Share
|
|
Jun 08
2021
|
Dennis M Lanfear President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
31,054
+5.59%
|
$0
$0.42 P/Share
|
|
Jun 06
2021
|
Dennis M Lanfear President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
300,000
+37.82%
|
$0
$0.42 P/Share
|
|
Apr 28
2021
|
Vladimir Vexler Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+21.42%
|
-
|
|
Apr 28
2021
|
Mc David Stilwell Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+40.0%
|
-
|
|
Apr 28
2021
|
Vincent R Anicetti Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+21.41%
|
-
|